ArticleScience translational medicine2023

Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models.

Scott Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.